Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s717. https://doi.org/10.25251/kvstvq23